8月19日 - ** NovaBay制药公司NBY.A股价盘后飙升75%至1.02美元
** NBY称已与私人投资者David Lazar签订了价值600万美元的证券购买协议
** Lazar还被任命为NBY的首席执行官,立即生效
** NBY表示,公司打算利用投资所得资金进行战略投资和/或收购
** 公司还预计在第三季度宣布特别现金股息
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.